News

Fujifilm Biotechnologies is preparing to open the first phase of its massive biologics manufacturing campus in Holly Springs, North Carolina, a site designed to rank among ...
JOHNSON & Johnson said on Thursday it would invest $2 billion in North Carolina as it aims to expand its US manufacturing presence amid looming drug import duties proposed by President Donald Trump's ...
Kodiak Sciences' pipeline, led by tarcocimab, targets less frequent dosing for retinal diseases but faces tough competition ...
These were among the concerns of a recent regulatory inspection of a key, but historically troubled, manufacturing plant that ...
Whether it’s a cook, a home health aide, or a direct support professional, domestic workers are critical for so many people ...
U.S. pharma bounced back in Q2, and in this episode of "The Top Line," Fierce Pharma's Eric Sagonowsky and Kevin Dunleavy ...
The FDA has identified critical lapses at a production facility operated by Novo Nordisk that is used by several drugmakers, ...
Healthcare stocks trade at a 30-year discount, with XLV showing signs of rebound as Buffett and hedge funds boost exposure.
Regeneron Pharmaceuticals faced a setback as the FDA postponed its decision on EYLEA HD's approvals to late 2025. This delay ...
J&J said on Thursday it has reached a 10-year agreement with Tokyo-based contract drug developer Fujifilm Biotechnologies for ...